BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.770

-0.260 (-12.81%)

At close: Jun 27, 2025, 4:00 PM

1.860

+0.090 (5.08%)

After-hours: Jun 27, 2025, 7:39 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Neuroscience and Immuno-oncology Drugs	1.38M	Log In
Neuroscience and Immuno-oncology Drugs Growth	268.00%	Log In

Revenue by Geography

Fiscal year is January - December.